Akari Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $16,806,000.
Profit Margin
| 2014 | 0 | -9.64M | |
|---|---|---|---|
| 2015 | 0 | -45.31M | |
| 2016 | 0 | -18.14M | |
| 2017 | 0 | -27.92M | |
| 2018 | 0 | -19.95M | |
| 2019 | 0 | -21.76M | |
| 2020 | 0 | -17.59M | |
| 2021 | 0 | -17.60M | |
| 2022 | 0 | -6.97M | |
| 2023 | 0 | -10.00M |
AKTX Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 3.99K | 3.70K | 4.12K | 8.90K | 19.20K | 35.84K | 42.4K | 39.77K | 10.15K | 0 |
Gross profit | -3.99K | -3.70K | -4.12K | -8.90K | -19.20K | -35.84K | -42.4K | -39.77K | -10.15K | 0 |
Operating exp. | ||||||||||
Research and development | 12.13M | 9.56M | 9.13M | 12.19M | 16.64M | 15.58M | 23.28M | 17.30M | 5.79M | 6.41M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 16.80M | 23.89M | 17.21M | 20.10M | 24.88M | 23.80M | 34.95M | 27.24M | 11.30M | 10.17M |
Operating income | -16.80M | -23.08M | -17.21M | -17.98M | -24.87M | -19.99M | -34.95M | -27.24M | -30.58M | -10.17M |
Other income (expenses), net | 6.79M | 5.34M | -210.10K | 899.35K | 117K | -3.50M | 2.38M | 8.96M | -14.72M | 567.56K |
Income before tax | -10.00M | -17.74M | -17.42M | -20.45M | -24.75M | -23.5M | -32.57M | -18.14M | -45.31M | -9.64M |
Income tax expense | 0 | -10.77M | 182.61K | -2.85M | -2.98M | -3.55M | -4.65M | -43.96K | 3.00M | 0 |
Net income | -10.00M | -6.97M | -17.60M | -17.59M | -21.76M | -19.95M | -27.92M | -18.14M | -45.31M | -9.64M |
Earnings per share | ||||||||||
Basic EPS | -2.04 | -2.23 | -8.2 | -11.14 | -23.77 | -1.26 | -2.24 | -1.54 | -5.32 | -11.28 |
Diluted EPS | -2.04 | -2.23 | -8.2 | -11.14 | -23.77 | -1.26 | -2.24 | -1.54 | -5.32 | -11.28 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |